Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Dutch Minister Demands ‘Socially Acceptable’ Price For Gilead’s Trodelvy
Apr 21 2023
•
By
Francesca Bruce
Dutch health technology appraisal body has advised that Gilead's Trodelvy is not cost-effective without discount • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Europe
More from Geography